Adherence to fibromyalgia treatment: challenges and impact on the quality of life

Abstract

BACKGROUND AND OBJECTIVES: Fibromyalgia is a chronic and idiopathic syndrome, characterized by a general distributed pain, more prevalent in women. Its pathophysiology remains unclear. Its chronicity implies an exclusively symptomatic treatment, often unsatisfactory. The lack of adherence to the established treatment is quite common. The objective of this study is to present a review of the adherence to the fibromyalgia syndrome treatment. CONTENTS: The concept of adherence to the fibromyalgia syndrome treatment, its classification, the identification of its measurement options, and the detection of its causes are detailed, revised and updated. CONCLUSION: The review of the literature regarding the adherence to the fibromyalgia syndrome treatment points to a large number of nonconformity of prescription, in general with the prevalence of the adoption of the reduction of the recommended dose and the interruption of the treatment, over possible overdoses and self-medication. The study of the causes that led to the non-adherence to the treatment elects the characteristics of the syndrome as the great villain for its occurrence. However, other associated factors such as the age of the subject with fibromyalgia, the intensity of the pain, the established polypharmacy, the quality of the doctor-patient relationship and the socioeconomic variables were also listed. The patient's quality of life was always higher in patients with higher adherence to treatment and persistence. Patients' quality of life indices may indicate the level of commitment to treatment adherence, and vice versa.

Recruitment characteristics and non-adherence associated factors of fibromyalgia patients in a randomized clinical trial: A retrospective survival analysis

“…Moreover, in oncology trials, moderate to severe depressive symptoms were associated with a lower adherence [ 67 ]. However, a recent review of adherence to fibromyalgia treatment did not include anxiety as a relevant factor for adherence [ 68 ]. Mood disorders such as anxiety and depression are likely to be important factors as they have the potential to impair motivation, which may affect the willingness and ability to follow and complete a treatment program.…”

Untitled

“…Em relação aos custos totais, os custos indiretos corresponderam a uma variação de 62,4% a 89,5%. EUA, Alemanha, Espanha e França foram os países com custos indiretos maiores associados à FM, refletindo a perda de produtividade do paciente por incapacidade funcional, a diminuição no número de horas e dias trabalhados, as altas taxas de desemprego e a retirada precoce do mercado de trabalho por motivo de invalidez (Oliveira Júnior & Ramos, 2019).…”

“…A FM é reconhecida pelos serviços de saúde como a condição reumatológica com maior ascensão na busca por cuidados em saúde. Na Espanha, pacientes com FM ocupam de 10%-20% das consultas reumatológicas e de 5%-8% das consultas com clínicos gerais (Oliveira Júnior & Ramos, 2019). Nos Estados Unidos (EUA), estima-se que 200.000 hospitalizações anualmente estejam associadas à FM (Haviland et al, 2011).…”

Osteonecrose Em Paciente Feminino Acometida Por Fibromialgia: Relato De Caso.

“…Caracterizada por dores musculoesqueléticas difusas, além de interferir no sono, causar fadiga constante, rigidez corporal e até desordens psíquicas (49% a 80% dos pacientes tem depressão), ou seja, uma síndrome debilitante. Sua prevalência varia de 0,2% a 6,26% da população (MATTOS; LUZ, 2012;FRANCISCONI, 2014;RAMOS, 2019;SOCIEDADE MINEIRA DE REUMATÓLOGIA, 2020;MEDLEY, 2020;GRAMINHA et al 2020). A FM é considerada uma das causas reumatológicas mais frequentes (HEYMAAN et al, 2017).…”

“…Assim, em consonância com a Convenção da ONU, em 2006, a Lei Federal nº 13.146/2015, regulamenta com base no artigo 2º da ONU (MPPR, 2017):Art. 2º Considera-se pessoa com deficiência aquela que tem impedimento de longo prazo de natureza física, mental, intelectual ou sensorial, o qual, em interação com uma ou mais barreiras, pode obstruir sua participação plena e efetiva na sociedade em igualdade de condições com as demais pessoas RAMOS, 2019;. MEDLEY, 2020; GRAMINHA et al, 2020).…”